Table 3.
Leaf gs | Leaf Ci | Leaf TSP | Leaf Rubisco Vt | Leaf Rubisco Act % | |
---|---|---|---|---|---|
WT | 0.26 ± 0.01 | 292 ± 5 | 7.44 ± 1.56 | 46.9 ± 12.1 | 65.9 ± 7.5 |
WT + ABA | 0.14 ± 0.03 | 245 ± 29 | 8.10 ± 1.54 | 43.7 ± 10.4 | 66.4 ± 3.2 |
% change after ABA treatment | − 47 | − 16 | N.s. | N.s. | N.s. |
Az34 | 0.39 ± 0.05 | 332 ± 9 | 3.57 ± 0.39 | 17.0 ± 1.4 | 76.0 ± 2.9 |
Az34 + ABA | 0.08 ± 0.02 | 234 ± 14 | 3.81 ± 0.4 | 19.8 ± 2.8 | 56.3 ± 3.8 |
% change after ABA treatment | − 79 | − 30 | N.s. | N.s. | − 26 |
Genotype | 0.017 | 0.081 | < 0.001 | < 0.001 | 0.601 |
ABA treatment | < 0.001 | < 0.001 | 0.839 | 0.960 | < 0.001 |
Genotype * ABA treatment | < 0.001 | 0.009 | 0.200 | 0.450 | < 0.001 |
The percentage change in response to ABA treatments is calculated when significant. Data are mean ± SE of 4 replicates. Results from two-way ANOVA (P values) are presented for Genotype, ABA treatment and their interaction
N.s. not significant